Back
Ascendis Pharma A/S Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
ASND
Ascendis Pharma A/S
Last Price:
$200.02
Seasonality Move:
19.56%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.
Ascendis Pharma A/S Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.47 | Sell |
| 20-day SMA: | 206.98 | Sell |
| 50-day SMA: | 205.78 | Sell |
| 200-day SMA: | 182.32 | Buy |
| 8-day EMA: | 205.13 | Sell |
| 20-day EMA: | 206.26 | Sell |
| 50-day EMA: | 204.64 | Sell |
| 200-day EMA: | 184.52 | Buy |
Ascendis Pharma A/S Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 44.76 | Sell |
| Chaikin Money Flow: | 14533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.09 - 213.85) | Sell |
| Bollinger Bands (100): | (192.48 - 209.22) | Sell |
Ascendis Pharma A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ascendis Pharma A/S Stock
Is Ascendis Pharma A/S Stock a Buy?
-
Ascendis Pharma A/S share price is 199.99 while ASND 8-day simple moving average is 207.47, which is a Sell signal.
-
The stock price of ASND is 199.99 while Ascendis Pharma A/S 20-day SMA is 206.98, which makes it a Sell.
-
Ascendis Pharma A/S 50-day simple moving average is 205.78 while ASND share price is 199.99, making it a Sell technically.
-
ASND stock price is 199.99 and Ascendis Pharma A/S 200-day simple moving average is 182.32, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
40
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy or a Sell?
-
Ascendis Pharma A/S stock is rated a SellThe current Ascendis Pharma A/S [ASND] share price is $199.99. The Score for ASND is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma A/S Stock Info
Market Cap:
12.2B
Price in USD:
199.99
Share Volume:
1.8M
Ascendis Pharma A/S 52-Week Range
52-Week High:
229.94
52-Week Low:
118.03
Sell
40
Ascendis Pharma A/S (ASND)
is a Sell
Ascendis Pharma A/S Share Price Forecast
-
What is the Ascendis Pharma A/S stock price today?The Ascendis Pharma A/S stock price is 199.99 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma A/S> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma A/S overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma A/S is overvalued.
Is Ascendis Pharma A/S Stock a Buy?
-
Ascendis Pharma A/S share price is 199.99 while ASND 8-day exponential moving average is 205.13, which is a Sell signal.
-
The stock price of ASND is 199.99 while Ascendis Pharma A/S 20-day EMA is 206.26, which makes it a Sell.
-
Ascendis Pharma A/S 50-day exponential moving average is 204.64 while ASND share price is 199.99, making it a Sell technically.
-
ASND stock price is 199.99 and Ascendis Pharma A/S 200-day simple moving average is 184.52, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma A/S
Is Ascendis Pharma A/S a good investment?
-
Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.00 per share, and an increase next year of $7.73 per share.
Technical Analysis of Ascendis Pharma A/S
Should I short Ascendis Pharma A/S stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Ascendis Pharma A/S is a Sell
-
Ascendis Pharma A/S Relative Strength Index (RSI) is 44.76, which suggest Ascendis Pharma A/S is oversold
-
The Bollinger Bands (25) for Ascendis Pharma A/S is (202.09 - 213.85), which suggest Ascendis Pharma A/S is a Sell
-
The Bollinger Bands (100) for Ascendis Pharma A/S is (192.48 - 209.22), which suggest Ascendis Pharma A/S is a Sell
* Ascendis Pharma A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.